Views provided by UsageCounts
Summarized results of RNA-sequencing performed within THOR (targeting smooth muscle cells in atherosclerosis). THOR is a collaborative project of Aarhus University and Novo Nordisk A/S as a part of the Open Discovery Innovation Network (ODIN) initiative. See detailed data description in the file "DESCRIPTION.md".
THOR is funded by the Novo Nordisk Foundation (grant number NNF20SA0061466).
cardiovascular disease, atherosclerosis, RNA-seq, smooth muscle cell
cardiovascular disease, atherosclerosis, RNA-seq, smooth muscle cell
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 11 |

Views provided by UsageCounts